Santiago Arroyo
Director/Board Member en H. LUNDBECK A/S .
Fortuna: 971 100 $ al 31/03/2024
Perfil
En la actualidad, Santiago Arroyo ocupa el cargo de Director Médico y Vicepresidente Senior de Desarrollo en Momenta Pharmaceuticals, Inc. El Dr. Arroyo también forma parte del consejo de administración de H. Lundbeck A. Anteriormente, el Dr. Arroyo ocupó el cargo de Director Médico de Bioterapéutica en Pfizer Inc., Director Médico en Boston Pharmaceuticals, Inc., Jefe de Neurociencias y Medicina de Descubrimiento en Bristol Myers Squibb Co., Jefe de Desarrollo Clínico Global en Eisai Co., Ltd., Profesor Asociado en el Hospital Clínico de Barcelona y Profesor Asociado en The Medical College of Wisconsin, Inc. Santiago Arroyo se doctoró en la Universidad Autónoma de Madrid y se doctoró en la Universidad de Barcelona.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 06/02/2024 | 39 000 ( 0.13% ) | 971 100 $ | 31/03/2024 |
Cargos activos de Santiago Arroyo
| Empresas | Cargo | Inicio |
|---|---|---|
| H. LUNDBECK A/S | Director/Board Member | 23/03/2021 |
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31/03/2023 |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Director/Board Member | 02/05/2023 |
Antiguos cargos conocidos de Santiago Arroyo.
| Empresas | Cargo | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 13/11/2022 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/10/2015 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2007 |
Hospital Clínic de Barcelona
 Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Corporate Officer/Principal | 01/01/2003 |
Formación de Santiago Arroyo.
| University of Barcelona | Doctorate Degree |
| Universidad Autónoma de Madrid | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 7 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Hospital Clínic de Barcelona
Hospital Clínic de Barcelona Hospital/Nursing ManagementHealth Services Hospital Clínic de Barcelona is a healthcare company based in Barcelona, Spain. The Spanish company operates a website for Hospital Clínic and IDIBAPS. The CEO of the private company is Josep Maria Campistol. | Health Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Health Technology |
- Bolsa de valores
- Insiders
- Santiago Arroyo
